MWW Group named Ame Wadler EVP, chief management officer and global healthcare practice leader.
Wadler, who was previously chief strategic officer and global healthcare practice chair for Burson-Marsteller, is charged with leading the strategic direction of the agency, along with the global healthcare practice for MWW Group.
She will also assume responsibility for devising new thought leadership platforms for the agency and driving practice integration across all platforms.
Kempner said: “Ame will be leveraging that vast experience and expertise to expand our senior management team structure and scale the agency’s operations and management framework for continued growth, both domestically and abroad.”
At Burson, Wadler is credited with overseeing the launches of Botox Cosmetic, Enbrel and the reintroduction of silicone gel breast implants to the US.
From the January 01, 2008 Issue of MM+M - Medical Marketing and Media
